Managing Director in Goldman Sachs' Public Sector and Infrastructure Group, with over two decades of investment banking experience serving state and local governments and public utility systems.

Chief Financial and Administrative Officer of Moffitt Cancer Center, and the 2018 Tampa Bay Business Journal CFO of the Year.

Former Executive Vice President of Corporate Affairs and Market Access for Celgene and former Chief of Staff to New Jersey Governor Chris Christie.

The James F. Holland Professor of Medicine at the Icahn School of Medicine at Mount Sinai, holding patents for the discovery of human granulocyte colony stimulating factor.

Data scientist leading the Therapeutics Data Science Initiative at MD Anderson Cancer Center, who developed canSAR.ai, the world's largest public cancer drug discovery platform.

Retired KPMG partner with more than 30 years of experience in AI and management consulting, who led the firm's AI transformation office and U.S. adoption strategy.

Chief Executive Officer and Chairman of Koppers, and a board member of ATI Inc. and Highmark Inc.

Technology executive with four decades of leadership experience, having served as President and CEO of OpenText, Canada's largest software company.

Professor of Pediatrics at Emory University and Director of the Leukemia and Lymphoma Program at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta.

Chief Scientific Officer of Santé Ventures, a venture capital fund focused on healthcare and life sciences.

Former President of Commercial Operations at Builders FirstSource, with a career spanning executive roles at BMC and Stock Building Supply.

Retired Chairman and CEO of Boehringer-Ingelheim USA, with more than 30 years of experience across the pharmaceutical industry.

Biopharmaceutical executive and venture capital investor with over 35 years of experience, involved in the development of five approved therapies.

Global healthcare executive serving as Senior Advisor at TowerBrook Advisors and former President and CEO of Intermountain Healthcare.

Senior Advisor to the Chair at DLA Piper and former Vice Chairman of American International Group, overseeing its global legal and compliance functions.

Laurel Gebroe Family Professor of Hematology/Oncology at Weill Cornell Medicine, with research focused on the epigenetic basis of blood cancers.

Retired nine-year NFL veteran and Super Bowl LIV champion who launched the organization's Scholarship for Blood Cancer Survivors in honor of his late mother.

Chief Scientific Officer and Executive Vice President of Investments at Royalty Pharma, with more than 25 years of biopharma investing experience.

Pediatric hematologist-oncologist at Texas Children's Cancer Center focused on immunotherapy for leukemia and lymphoma and reducing cancer health disparities.

Senior Managing Director Emeritus at Bridge Investment Group and former CEO of Bridge Commercial Real Estate, with over 30 years in commercial real estate.

Principal at Stern IR, Inc., an investor relations consulting firm specializing in biotechnology companies.

Strategic Advisor at Good Hill Partners with more than 30 years in the alternative investment industry, and former Chair of the Board of Directors.